The characteristics of nuclear medicine diagnosis and treatment are:

Radioiodine therapy ¹³¹I for differentiated thyroid cancer.

The department is now equipped with 12 standardized radionuclide treatment beds and fully automatic decay cell system. The number of hospitalizations for thyroid cancer radioactive iodine treatment reached 1200 person-times per year. The outpatient exceeds 10,000 person-times per year, and the patient covers the three northeastern provinces.

The department also conducts ¹³¹I treatment of hyperthyroidism, ⁹⁰Sr applicator for the treatment of hemangioma, keloid; ⁸⁹Sr in the treatment of bone metastases, ³²P treatment of hematological tumors, ¹²⁵I particle therapy for solid tumors and many other radionuclide projects.